Helena Kasem-Bejr

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Disrupted visual-to-semantic dynamics promote visual hallucinations in Parkinson's disease.

Disrupted visual-to-semantic dynamics promote visual hallucinations in Parkinson's disease.

Journal: NPJ Parkinson's disease
Published: September 22, 2025

Brain-derived extracellular vesicle proteomics reveals neuroprotection induced by the ARB candesartan in Parkinson's disease patients.

Brain-derived extracellular vesicle proteomics reveals neuroprotection induced by the ARB candesartan in Parkinson's disease patients.

Journal: NPJ Parkinson's disease
Published: July 08, 2025

Efficacy and safety of efavirenz in Niemann-Pick disease type C.

Efficacy and safety of efavirenz in Niemann-Pick disease type C.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: April 16, 2025

Barcelona Progressive Supranuclear Palsy (PSP) Registry: Clinical, Oculomotor, and Cerebrospinal Fluid Markers; from Suggestive to Definite Cases.

Barcelona Progressive Supranuclear Palsy (PSP) Registry: Clinical, Oculomotor, and Cerebrospinal Fluid Markers; from Suggestive to Definite Cases.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: April 16, 2025

Parkinson disease psychosis: from phenomenology to neurobiological mechanisms.

Parkinson disease psychosis: from phenomenology to neurobiological mechanisms.

Journal: Nature reviews. Neurology
Published: December 13, 2023

Facial emotion recognition deficits are associated with hypomimia and related brain correlates in Parkinson's disease.

Facial emotion recognition deficits are associated with hypomimia and related brain correlates in Parkinson's disease.

Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: October 03, 2023

A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease.

A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease.

Journal: Parkinsonism & related disorders
Published: January 11, 2023

The role of attentional control over interference in minor hallucinations in Parkinson's disease.

The role of attentional control over interference in minor hallucinations in Parkinson's disease.

Journal: Parkinsonism & related disorders
Published: May 29, 2022

Clinical and structural brain correlates of hypomimia in early-stage Parkinson's disease.

Clinical and structural brain correlates of hypomimia in early-stage Parkinson's disease.

Journal: European journal of neurology
Published: May 11, 2022

A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease.

A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease.

Journal: Frontiers in neurology
Published: January 31, 2022

Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson's disease.

Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson's disease.

Journal: Parkinsonism & related disorders
Published: December 12, 2021

Predicting Impulse Control Disorders in Parkinson Disease through Incentive Biomarkers.

Predicting Impulse Control Disorders in Parkinson Disease through Incentive Biomarkers.

Journal: Annals of neurology
Published: November 05, 2021
Showing 1-12 of 28

Last Updated: 09/26/2026